Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Leonardo Malimpensa
Institution:
Sapienza University of Rome
Observed institutions:
Istituto Neurologico Mediterraneo,
Sapienza University of Rome
ORCID:
0000-0002-0945-4282
Observed ORCID:
0000-0002-0945-4282
OpenAlex ID:
A5050825967
Exploring easily accessible neurophysiological biomarkers for predicting Alzheimer’s disease progression: a systematic review
2024
·
Matteo Costanzo
, Carolina Cutrona
, et al.
·
Alzheimer s Research & Therapy
·
44
PDF
Neural bases of motor fatigue in multiple sclerosis: A multimodal approach using neuromuscular assessment and TMS-EEG
2023
·
Giorgio Leodori
, Marco Mancuso
, et al.
·
Neurobiology of Disease
·
27
PDF
The Impact of Cytomegalovirus Infection on Natural Killer and CD8+ T Cell Phenotype in Multiple Sclerosis
2024
·
Valentina Perri
, Maria Antonella Zingaropoli
, et al.
·
Biology
·
17
PDF
Cladribine and ocrelizumab induce differential miRNA profiles in peripheral blood mononucleated cells from relapsing–remitting multiple sclerosis patients
2023
·
Ivan Arisi
, Leonardo Malimpensa
, et al.
·
Frontiers in Immunology
·
17
Multiple sclerosis-disease modifying therapies affect humoral and T-cell response to mRNA COVID-19 vaccine
2022
·
Federica Dominelli
, Maria Antonella Zingaropoli
, et al.
·
Frontiers in Immunology
·
14
PDF
Insight into motor fatigue mechanisms in natalizumab treated multiple sclerosis patients with wearing off
2024
·
Giorgio Leodori
, Marco Mancuso
, et al.
·
Scientific Reports
·
11
PDF
Frailty and relapse activity in multiple sclerosis: A longitudinal observation
2023
·
Viola Baione
, Marco Canevelli
, et al.
·
Multiple Sclerosis and Related Disorders
·
10
Therapeutic choices and disease activity after 2 years of treatment with cladribine: An Italian multicenter study ( CladStop )
2024
·
Irene Schiavetti
, Alessio Signori
, et al.
·
European Journal of Neurology
·
9
PDF
The multidimensional assessment of body representation and interoception in multiple sclerosis
2024
·
Simona Raimo
, Gina Ferrazzano
, et al.
·
Multiple Sclerosis and Related Disorders
·
8
Neurophysiological and clinical biomarkers of secondary progressive multiple sclerosis: A cross-sectional study
2023
·
Matteo Tartaglia
, Marco Canevelli
, et al.
·
Frontiers in Neurology
·
7
PDF
Real-World 24-Month Outcomes of Ofatumumab in Relapsing Multiple Sclerosis: Efficacy, Safety, and the Impact of Frailty
2025
·
Gina Ferrazzano
, Roberta Fantozzi
, et al.
·
Neurology and Therapy
·
5
PDF
Evaluation of BAFF, APRIL and CD40L in Ocrelizumab-Treated pwMS and Infectious Risk
2023
·
Maria Antonella Zingaropoli
, Patrizia Pasculli
, et al.
·
Biology
·
5
PDF
Frailty and urinary symptoms share pathophysiological mechanisms involved in disease progression in people with multiple sclerosis
2025
·
Angelo Di Santo
, Leonardo Malimpensa
, et al.
·
Neurological Sciences
·
4
Exploring miRNAs’ Based Modeling Approach for Predicting PIRA in Multiple Sclerosis: A Comprehensive Analysis
2024
·
Tommaso Gosetti di Sturmeck
, Leonardo Malimpensa
, et al.
·
International Journal of Molecular Sciences
·
4
PDF
Improvement of fatigue, depression, and processing speed two weeks post Natalizumab infusion in Multiple Sclerosis: No difference between standard and extended interval dosing schedules
2024
·
Giorgio Leodori
, Marco Mancuso
, et al.
·
Multiple Sclerosis and Related Disorders
·
3
Resting-State EEG Microstates as Dynamic Biomarkers of Network Dysfunction and Cognitive Impairment in Patients With Multiple Sclerosis
2026
·
Giorgio Leodori
, Davide Maccarrone
, et al.
·
Neurology
·
2
Real-world experience with cladribine tablets in people with multiple sclerosis: effectiveness data from a multicenter Italian study
2025
·
Matteo Lucchini
, Giovanna Borriello
, et al.
·
Therapeutic Advances in Neurological Disorders
·
2
TMS–EEG signatures of motor network dysfunction in multiple sclerosis
2026
·
Giorgio Leodori
, Marco Mancuso
, et al.
·
Brain Communications
·
1
Long‐Term Disease Control Following Completion of Cladribine Treatment in Multiple Sclerosis: Extended Follow‐Up of the CladStop Cohort
2026
·
Irene Schiavetti
, Alessio Signori
, et al.
·
European Journal of Neurology
PDF
Studying Botulinum Toxin Diffusion in Spastic Patients Using High-Density Surface EMG: A Clinical and Electrophysiological Perspective
2026
·
Marco Gagliardi
, Leonardo Malimpensa
, et al.
·
Toxicon
Moral decision making and moral judgment in multiple sclerosis.
2025
·
Federica Satriano
, Antonella Di Vita
, et al.
·
Neuropsychology
Show more works
View as search
Works count:
21
Citation count:
189
H-index:
8
I10-index:
7
Year
Topic
Type